804 related articles for article (PubMed ID: 11177538)
21. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.
Preuss E; Treschow A; Newrzela S; Brücher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
Hum Gene Ther; 2010 Aug; 21(8):929-41. PubMed ID: 20201626
[TBL] [Abstract][Full Text] [Related]
22. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
[TBL] [Abstract][Full Text] [Related]
23. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
[TBL] [Abstract][Full Text] [Related]
24. Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene.
Jung J; Hackett NR; Pergolizzi RG; Pierre-Destine L; Krause A; Crystal RG
Hum Gene Ther; 2007 Dec; 18(12):1182-92. PubMed ID: 18021021
[TBL] [Abstract][Full Text] [Related]
25. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase.
Wei SJ; Chao Y; Hung YM; Lin WC; Yang DM; Shih YL; Ch'ang LY; Whang-Peng J; Yang WK
Exp Cell Res; 1998 May; 241(1):66-75. PubMed ID: 9633514
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
[TBL] [Abstract][Full Text] [Related]
27. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
[TBL] [Abstract][Full Text] [Related]
28. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
[TBL] [Abstract][Full Text] [Related]
29. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
30. Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors.
Smiley WR; Laubert B; Howard BD; Ibañez C; Fong TC; Summers WS; Burrows FJ
Hum Gene Ther; 1997 May; 8(8):965-77. PubMed ID: 9195219
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.
Zhang JH; Wan MX; Pan BR; Yu B
Cancer Biol Ther; 2004 Nov; 3(11):1075-80. PubMed ID: 15477756
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
[TBL] [Abstract][Full Text] [Related]
34. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
Hu WX; Zeng ZJ; Luo SQ; Chen Q
Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
[TBL] [Abstract][Full Text] [Related]
35. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
37. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
[TBL] [Abstract][Full Text] [Related]
38. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
39. Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.
Peretti S; Schiavoni I; Pugliese K; Federico M
Mol Ther; 2005 Dec; 12(6):1185-96. PubMed ID: 16095973
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]